ALT vs EPAM · rev $20.0K vs P/E 14, rev $4.73B
Altimmune Inc (ALT) versus EPAM Systems Inc (EPAM) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
EPAM Systems Inc (EPAM) is a information technology services company listed on US.
Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.
Latest reported EPAM revenue for 2024-12-31 was $4.73B. Net income was $454.5M. Revenue was up 0.8% from 2023-12-31 to 2024-12-31. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
ALT currently screens at market cap $527.0M. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
Not investment advice. Open the ALT and EPAM stock pages for the full models.
Not investment advice.